Seefinish Insights Trends news knowledge Discovery

ReadR

ReadR

ReadR: Read and Share all content, headlines, news and trends results with Seefinish ReadR App.

Discover Content : Trends

Discover real-time trending topics, news headlines, twitter trends, google trends, hashtags, and content from different countries in the world.

Search Here

Navigation Tabs

Top Countries

Select Country:🌐

Worldwide 🌍 | Nigeria 🇳🇬 | South Africa 🇿🇦 | Kenya 🇰🇪 |Brazil 🇧🇷| Canada 🇨🇦 | United Kingdom 🇬🇧| United States 🇺🇸

See all other continents, locations, categories and associated headlines or trending informations here using

America:
Brazil 🇧🇷| Canada 🇨🇦 | United States 🇺🇸

Africa:
Algeria 🇩🇿 | Egypt 🇪🇬 | Ghana 🇬🇭 | Kenya 🇰🇪 |Morocco 🇲🇦| Nigeria 🇳🇬 | South Africa 🇿🇦 | Zambia 🇿🇲 |

Middle East:
| Israel 🇮🇱|kuwait 🇰🇼 |Saudi Arabia 🇸🇦 |Turkey 🇹🇷| Cyprus 🇨🇾 |

Europe:
Finland 🇫🇮|France 🇫🇷| Hungary 🇭🇺 |Germany 🇩🇪| Italy 🇮🇹 | Poland | Slovakia 🇸🇰 | Switzerland 🇨🇭 | Spain | United Kingdom 🇬🇧

Australia/Oceania: 🌐
Australia 🇦🇺|New Zealand 🇦🇺

Asia:
China 🇨🇳 | Japan 🇯🇵| India 🇮🇳| Malaysia 🇲🇾| Philippines 🇵🇭 | Singapore 🇸🇬 |Thailand 🇹🇭 |

Show more
Show less

Headline : Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

Read more from the original article on here at www.cnbc.com.






Tags : #healthy #returns #eli #lilly #could #soon #become #first #1 #trillion #healthcare #stock


No. of Paragraph 30

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.

Earlier this month, Berkshire Hathaway topped $1 trillion in market value, the first non-tech company in the U.S. to do so. Soon, pharmaceutical giant Eli Lilly could become the first health-care company to join that club. 

Why? Eli Lilly is riding the soaring demand for its injectable weight loss drug Zepbound and diabetes medication Mounjaro, which are incretin drugs that mimic hormones produced in the gut to tamp down appetite and regulate blood sugar. Revenue from Mounjaro and Zepbound now account for almost 40% of Eli Lilly's total sales, according to its second-quarter results in August.  

The company is one of two dominant players in the weight loss drug market, which some analysts believe could be worth $150 billion by the end of the decade. Eli Lilly may also be pulling ahead of its main rival, Novo Nordisk, as it shows progress toward expanding the supply of its drugs. 

Read more from the original article on here at www.cnbc.com.


Related Headlines : Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock (in Google.com):

Hello, below you have a "Web" tab to read more content and an "Image" tab to get related pictures

Example : Trends, Country, News, Jobs, Scholarships, Investment, Business, Politics, Adverts, Fashion, Events, Technology and more.